Why the study?
Does Endothelin-1 increase thrombus formation and vasoconstriction in a rabbit vena jugularis thrombus model?
Does Endothelin-1 increase thrombus formation and vasoconstriction in a rabbit vena jugularis thrombus model?
In a rabbit model, ET-1 acts synergistically with thromboplastin to increase thrombus formation and regulates vascular tone via dose-dependent vasoconstriction.
Endothelins (ET) are the most important vasoconstrictors known, and administration results in contraction of vascular strips in man and experimental animals in vitro. We examined the effects of ET-1 on thrombus formation in rabbits. We used vasoconstrictor and thrombus forming agents and we selected an animal model, the vena jugularis thrombus model. In addition, intravascular endothelium was examined ultrastructurally. The ET-1 level is known to be high in patients with hypertension; if these patients also have atherosclerosis, then intravascular thrombus formation may increase. In the vena jugularis thrombus model, thromboplastin and ET-1 act synergistically to increase intravascular thrombus formation. On injection of ET-1 dose dependent vasoconstriction was shown in the vessel wall. Although similar maximal contraction is achieved, a decrease in vessel diameter is associated with increased potency of ET-1 and thromboplastin. The results suggest that ET-1 may regulate vascular tone through constriction of vessels.
No takes yet. Share an insight, caveat, or question.
Ulutin et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: